SHIM
RDY icon

Stone House Investment Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Stone House Investment Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.4K Buy
462
+448
+3,200% +$6.24K ﹤0.01% 417
2025
Q4 		$197 Buy
+14
New +$196 ﹤0.01% 803

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Stone House Investment Management's RDY Position: Q1 2026 in Review

Stone House Investment Management increased its Dr. Reddy's Laboratories (RDY) stake by 3,200% in Q1 2026, buying an estimated $6.24K and bringing the position to 462 shares worth $6.4K. The position accounts for ﹤0.01% of the portfolio, ranked #417.

Stone House Investment Management first reported a position in RDY in Q4 2025 and has held it in 2 quarters since. 248 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • Stone House Investment Management held 462 shares of Dr. Reddy's Laboratories worth $6.4K as of Q1 2026.
  • Stone House Investment Management bought 448 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $6.24K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Stone House Investment Management's portfolio in Q1 2026, its #417 holding.
  • Stone House Investment Management first reported a position in Dr. Reddy's Laboratories in Q4 2025 and has held it in 2 quarters since.
  • 248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Stone House Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.